Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors

The NRAS and BRAF genes are frequently mutated in melanoma, suggesting that the NRAS-BRAF-MEK-ERK signaling pathway is an important target for therapy. Two classes of drugs, one targeting activated BRAF and one targeting MEK, are currently undergoing clinical evaluation. We have analysed the NRAS an...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Stones, Clare J., Kim, Ji Eun, Joseph, Wayne R., Leung, Euphemia, Marshall, Elaine S., Finlay, Graeme J., Shelling, Andrew N., Baguley, Bruce C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2013
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3647113/
https://ncbi.nlm.nih.gov/pubmed/23658559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2013.00066
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky